awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39200835-217E0BF9-554C-471B-9974-21E0D318E067
Q39200835-217E0BF9-554C-471B-9974-21E0D318E067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39200835-217E0BF9-554C-471B-9974-21E0D318E067
Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax.
P2860
Q39200835-217E0BF9-554C-471B-9974-21E0D318E067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39200835-217E0BF9-554C-471B-9974-21E0D318E067
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2659a64b3c1e785991bb0f53d721e31f1c4c302
P2860
Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.